Probiotics for Treatment of Chalazion in Adults (NCT04342507) | Clinical Trial Compass
CompletedNot Applicable
Probiotics for Treatment of Chalazion in Adults
Italy20 participantsStarted 2019-02-01
Plain-language summary
There is growing evidence encouraging probiotics use in several diseases. The aim of the investigator's study is to define the possible beneficial impact of probiotics on adults suffering from chalazia.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* history of rapid onset of painful inflamed mass that had reached a stationary size for more than 2 months
* clinical appearance and location of the lesion
Exclusion Criteria:
* eyelid infection
* chalazion duration \< 1 month
* nonpalpable chalazion
* suspicion of malignancy
* comorbidities (constitutional atopy and seborrheic dermatitis, hormonal dysfunction, presence of irritable bowel disease, infectious mainly related to Staphylococcus aureus and Propionibacterium acnes, demodex mite infestation, vitamin A deficiency, arterial hypertension, diabetes and pregnancy)
* personal habits (smoking, eating disorders, etc.)